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 Introduction 
 Myelin is a highly specialized membrane that wraps around 
axons in the peripheral (PNS) and central (CNS) nervous systems. 
Although the function of myelin in facilitating the effi cient and 
rapid propagation of nerve impulses by saltatory conduction has 
long been known, the basic mechanisms that drive the extension 
and wrapping of the glial membrane around the axon remain 
poorly understood. During their development and differentia-
tion into myelin-forming cells, oligodendrocytes (OL) in the 
CNS and Schwann cells (SC) in the PNS undergo striking mor-
phological changes that involve the active remodeling of their 
cytoskeleton. Data from multiple studies have underscored the 
importance of the actin cytoskeleton in process extension and 
myelination by both SC and OL ( Fernandez-Valle et al., 1997 ; 
 Kim et al., 2006 ;  Bacon et al., 2007 ). 
 SC and OL express several regulatory actin-binding pro-
teins, which regulate actin polymerization and process forma-
tion ( Bacon et al., 2007 ). Pharmacological inhibition of actin 
polymerization has a negative effect on process extension, 
axonal ensheathment, differentiation, and myelination by both 
SC and OL ( Fernandez-Valle et al., 1997 ;  Bacon et al., 2007 ). 
Similarly, mice lacking WAVE1, an actin-binding protein im-
portant for lamellipodia formation, show defective OL morpho-
genesis and regional hypomyelination ( Kim et al., 2006 ). Despite 
the fact that myelin formation by glial cells appears to involve the 
assembly and progression of an inner mesaxon around one (SC) 
or several (OL) axons ( Bunge et al., 1989 ), the question still 
remains as to whether or not this process is driven by a common 
actin-polymerization mechanism and whether this is regulated 
in a similar fashion in the CNS and the PNS. Signifi cantly, several 
studies have shown that members of the small Rho-GTPase family, 
the main regulators of actin cytoskeleton dynamics, are also im-
portant for coordinating the formation and maintenance of the 
myelin sheath by SC and OL. Activation of Rac1 downstream 
of   1 integrin signaling has been implicated in process exten-
sion and axonal segregation and myelination by SC ( Benninger 
et al., 2007 ;  Nodari et al., 2007 ). In contrast, in the CNS, Rac1 
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 The most striking and reproducible effect of blebbistatin 
was a reduction in the number and size of MBP + segments that 
formed in cocultures ( Fig. 1, A and C ). These effects were 
dose-dependent, and at the highest dose used (50  μ M), myeli-
nation was completely abolished ( Fig. 1 C ). Because blebbi-
statin can interfere with cytokinesis and cell division ( Straight 
et al., 2003 ), we examined the effects of the drug on SC pro-
liferation and survival in the cocultures. There was no effect 
on cell survival based on the TUNEL assay but a small de-
crease in the index of BrdU incorporation between control and 
treated cultures was observed only at the highest doses of the 
drug (from 30% in control cultures to 20 – 24% in cultures 
treated with blebbistatin at 25 or 50  μ M; see Table S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200802091/DC1). 
Despite reduced proliferation, myelination could not be res-
cued in blebbistatin-treated cultures (at 10, 25, and 50  μ M) 
even when an excess of SC (10 6 instead of 10 5 ) were added 
to the cultures (unpublished data). Furthermore, cocultures 
treated with blebbistatin for 3 – 7 d and then maintained for ad-
ditional 1 – 2 wk without the drug showed normal myelination, 
which indicates that the effects of the drug are reversible. 
Thus, we conclude that the inhibition of myelination in these 
cultures was not caused by insuffi cient SC numbers or an ef-
fect on cell viability. 
 We also found that the addition of blebbistatin during the 
fi rst 24 – 72 h after switching the cultures to ascorbate-containing 
media had a more powerful effect in inhibiting myelination (un-
published data). Adding blebbistatin to cultures 4 or 7 d after 
myelin induction had no apparent effect on myelin formation. 
These results indicate that myosin II activity is critical at early 
stages of myelination. Closer examination of SC morphology 
in blebbistatin-treated cultures revealed several abnormalities: 
SC nuclei were round in shape and did not elongate along the 
axons (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200802091/DC1). Even among those cells that formed my-
elin, the nuclei appeared round and were asymmetrically local-
ized along the internode, in contrast to the elongated and 
centered nuclei characteristic of myelinating SC in control cul-
tures ( Fig. 1 B ). Although segments in blebbistatin-treated cultures 
were shorter than controls (P  < 0.0001;  Fig. 1 C ), they appeared 
to be of normal thickness. Costaining with antibodies to laminin 
and sodium channels (Fig. S2) also revealed that some SC in 
blebbistatin-treated cultures form multiple short segments, akin to 
the defects previously described after ROCK inhibition ( Melendez-
Vasquez et al., 2004 ). 
 The reduction in myelin formation was corroborated by 
signifi cantly decreased amounts of myelin proteins (MBP, P0, 
and myelin-associated glycoprotein) and transcription fac-
tors (Krox-20 and Oct6) based on Western blotting ( Fig. 1 D ). 
Basal lamina components such as laminin chains   2 and   1/  1 
were also reduced. Electron microscopy analysis of blebbi-
statin-treated cultures further confi rmed that SC appeared 
to be arrested at the premyelinating stage and were unable 
to properly ensheath and segregate axons ( Fig. 1 E ). Many 
large-diameter naked axons were seen in these cultures, and in 
some cases, they were segregated but remained unmyelinated 
( Fig. 1 F ). The basal lamina around the SC appeared thin and patchy 
and Cdc42, although dispensable for OL differentiation and 
myelination, appear to be important for myelin maintenance and 
stability ( Thurnherr et al., 2006 ). Although the role of Rho in 
myelination has not been evaluated directly, constitutive activa-
tion of Rho interferes with OL branching and maturation ( Wolf 
et al., 2001 ;  Liang et al., 2004 ), whereas its inactivation promotes 
plasma membrane condensation and differentiation in Olig-
neu cells ( Kippert et al., 2007 ). In the PNS, inactivation of Rho-
associated kinase (ROCK), a major downstream effector of Rho, 
does not prevent SC differentiation and myelination but results 
in aberrant myelin organization ( Melendez-Vasquez et al., 2004 ). 
Collectively, these contrasting effects of small GTPases function 
in myelinating glial cells suggest that the mechanisms control-
ling actin dynamics in SC and OL during differentiation and my-
elination are regulated differently. 
 The spatial and temporal regulation of actin interactions 
with specifi c binding proteins and myosin motors provides a mech-
anism for precisely regulating actin assembly and dynamics in a 
variety of higher-order cellular structures ( Chhabra and Higgs, 
2007 ). In nonmuscle cells, phosphorylation of the regulatory 
chain of the motor protein myosin II (MLC2) by ROCK is a key 
regulator of actomyosin assembly ( Conti and Adelstein, 2008 ). 
We have previously found that MLC2 phosphorylation is dra-
matically up-regulated at the onset of PNS myelination, and that 
inhibition of ROCK in myelinating cocultures results in a dra-
matic decrease of phosphorylated MLC2 levels and abnormal SC 
myelination ( Melendez-Vasquez et al., 2004 ). Using a combina-
tion of pharmacological and molecular tools, we have further in-
vestigated the specifi c role of myosin II during myelin formation 
by both SC and OL. We have found in this paper that myelina-
tion in the PNS and CNS is differentially regulated by myosin II. 
Myosin II is necessary for SC differentiation and myelination. 
In contrast, inhibition of myosin II activity in OL precursors does 
not interfere with their differentiation or their ability to form my-
elin but instead potentiates myelin formation in culture. Our results 
indicate that the mechanisms regulating glial cell cytoskeleton 
and myelin formation in the PNS and CNS are distinct. 
 Results 
 Inhibition of myosin II activity reduces the 
number and size of SC myelin segments 
 To study the role of myosin II in myelination, we fi rst examined 
the effects of blebbistatin, a specifi c inhibitor of nonmuscle 
myosin II ( Straight et al., 2003 ), in SC neuronal cocultures. SC 
were added to established dorsal root ganglion (DRG) neuron 
cultures with extensive neurite outgrowth. Cocultures were then 
switched to media containing ascorbate to promote basal lamina 
formation and myelination, with or without blebbistatin (1, 5, 
10, 25, and 50  μ M). As an additional control, some cultures 
were treated with an inactive enantiomer of blebbistatin at the 
same concentration ( Fig. 1 A ). Blebbistatin was well tolerated 
for the duration of the experiment, without any signifi cant effect 
on SC survival as measured by a TUNEL assay (unpublished 
data). After an additional 2 – 3 wk, cultures were fi xed and 
stained for myelin basic protein (MBP) to identify compact my-
elin sheaths. 
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 Myosin II is required for normal SC 
interactions with axons and myelination 
 To confi rm that the myelination defects observed in blebbi-
statin-treated cocultures were caused by inhibition of myosin II 
activity in SC and not by an effect of the drug on neurons, pri-
mary SC cultures were infected with lentivirus-expressing short 
hairpin RNA (shRNA) targeting the regulatory (light) chain of 
(not depicted), and they also exhibited abnormal branching 
and process extension. No obvious changes on the density/
morphology of axons ( Fig. 1 A ) or in the levels of axonal-
specifi c proteins such as Tau ( Fig. 1 D ) were observed be-
tween control and treated cultures. Collectively, these results 
suggest that myosin II inhibition greatly impairs differentia-
tion and myelination by SC in culture. 
 Figure 1.  Inhibition of myelination in SC cocultures 
treated with blebbistatin.  (A) 2-wk-old myelinating SC 
neuronal cocultures stained for MBP, Krox-20, and 
neuroﬁ lament. A signiﬁ cant reduction in myelin forma-
tion and Krox-20 expression was observed in cultures 
treated with the active (  ) blebbistatin enantiomer 
compared with control cultures and cultures treated 
with the inactive (+) enantiomer. (B) Myelinated seg-
ments formed in blebbistatin (  )-treated cultures 
(right) were shorter than in control cultures (left) and 
frequently exhibited rounded and off-centered SC nu-
clei (asterisks). (C) Quantitation of internode length 
and number in 2-wk-old cocultures. A dose-dependent 
reduction in both the total number (n) and the length 
of the myelinated segments was consistently observed 
in treated cultures compared with the control. At the 
highest dose of blebbistatin (50  μ M), myelination 
was completely abolished. Data in the graph repre-
sent mean  ± SEM from two independent experiments 
(two cultures per condition per experiment). ***, P  < 
0.0001. (D) Western blots from 2-wk-old cocultures, 
which conﬁ rm a signiﬁ cant reduction in the expres-
sion of myelin proteins, transcription factors, and lami-
nin chains in blebbistatin-treated cultures (T). Actin 
and Tau levels were comparable in both treated and 
control cultures. (E and F) Ultrastructural analysis of 
18-d-old myelinating cocultures treated with 25  μ M 
blebbistatin showing abnormalities in axon ensheath-
ing and segregation. (E) An SC on top of a bundle 
of axons appears arrested at a premyelinating stage. 
Many axons (asterisks) are surrounded by very short 
cytoplasmic processes (black arrowheads), which fail 
to completely wrap or segregate them in a 1:1 associ-
ation. Rough endoplasmic reticulum (red arrowheads) 
is very prominent in this cell. (F) A large segregated 
but nonmyelinated axon (ax), which is also contacted 
by a process (red asterisk) derived from a different 
SC. Many large-diameter naked axons are also ob-
served in this ﬁ eld (black asterisks). The arrowhead 
points to a very short cytoplasmic process failing 
to surround an axon. Bars: (A) 100  μ m; (B) 25  μ m; 
(E and F) 1  μ m. 
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with our inhibitor data, the amount of myelin formed in cultures 
established with myosin-defi cient SC was signifi cantly reduced 
( Fig. 2 A ). Western blotting also confi rmed a decrease in the 
amount of myelin proteins (MBP and P0) expressed in knock-
down cultures ( Fig. 2 B , right). Quantitation of the number and 
length of MBP + segments ( Fig. 2 C ) showed that in the absence 
of MLC2, the number of MBP + segments per fi eld was signifi -
cantly reduced (P  < 0.001) and were on average 30% shorter 
than controls (P  < 0.001). 
 Myosin-defi cient SC exhibited a morphology akin to that 
observed in blebbistatin-treated cultures with rounded nuclei 
myosin II (hence called MLC2). Phosphorylation of MLC2 
activates the motor activity of myosin II and is required for 
assembly of myosin II heavy chains ( Bresnick, 1999 ). As controls, 
SC cultures were infected with the empty lentiviral vector 
(pLL3.7) or nontargeting (scrambled) lentivirus (shSCR). West-
ern blotting confi rmed a signifi cant and specifi c reduction in the 
amount of MLC2, phospho-MLC2, and both myosin IIA and 
IIB in SC infected with two different constructs expressing 
shMLC2 used separately (not depicted) or in combination ( Fig. 2 B , 
left). Infected SC were then seeded onto DRG neuronal cultures 
and kept under myelinating conditions for 2 – 3 wk. In agreement 
 Figure 2.  Knockdown of myosin II by shRNA results in abnormal SC morphology and prevents proper interactions with axons and myelination. (A) SC 
infected with lentivirus expressing shRNA against the regulatory chain of myosin II (shMLC) or a scrambled nontargeting sequence (shSCR) were seeded 
onto puriﬁ ed DRG neurons and allowed to myelinate. After 18 d, cocultures were stained for MBP and neuroﬁ lament. A clear reduction in the amount 
of myelin formed in cocultures by SC expressing shMLC compared with those expressing nontargeting (SCR) shRNA was consistently observed. (B, left) 
Validation of protein knockdown in SC cultures. Western blots from control noninfected SC cultures (NI) and cultures infected with either vector alone (V) 
or vectors expressing targeting (MLC) and nontargeting (SCR) shRNA showing a marked reduction in the levels of phosphorylated MLC, total MLC, and 
both isoforms of myosin II only in SC cultures infected with lentivirus shMLC. (right) Western blots of myelinating cocultures showing a marked reduction in 
the total amount of myelin proteins (P0 and MBP) in cocultures established with SC infected with shMLC. Control for vector expression (GFP) and protein 
loading (actin) are also shown. (C) Quantitation of MBP + segment number and length formed in 18-d-old myelinating cocultures by SC infected with shMLC 
compared with nontargeting control (shSCR). Data represent mean  ± SEM from two independent experiments (three cultures per condition per experiment). 
(D) 5-d-old cocultures stained for GFP to visualize infected SCs and also for neuroﬁ lament and laminin   2. SC expressing MLC shRNA have round nuclei 
and extend multiple long and thin processes. Knockdown cultures also showed a marked reduction in the expression of laminin   2 chain and impaired 
basal lamina assembly. In control cultures (shSCR), SC exhibited the characteristic elongated morphology upon contact with the axons. (E) Detail of an SC 
expressing shMLC-GFP in coculture with axons (blue). The cell has multiple processes, some of which appear to contact axons (asterisks), whereas others 
fail to do so (arrowheads). Bars: (A) 100  μ m; (D) 100  μ m; (E) 20  μ m. 
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played abundant cortical actin and stress fi bers ( Fig. 3 A ), where 
myosin light chain (MLC) staining was also found ( Fig. 3 B , 
inset 1). Staining for the cell adhesion molecule N-cadherin, a 
protein thought to mediate the initial growth of SC processes and 
their alignment with axons ( Wanner and Wood, 2002 ), was en-
riched at membrane protrusions ( Fig. 3 B ), together with ERM (not 
depicted). In randomly polarized (front-to-back) SC, N-cadherin 
was concentrated at the leading edge protrusions and also at the 
tip of the cell tail ( Fig. 3 B , inset 2). MLC staining was also en-
riched at the retracting tail ( Fig. 3 B , inset 2), where it colocalized 
with vinculin ( Fig. 3 , inset 4), a marker of focal adhesions ( Fig. 3 B , 
inset 3). Treatment with blebbistatin (15 – 60 min) resulted in strik-
ing changes in the organization of the actin cytoskeleton ( Fig. 3 C ). 
Changes included loss of stress fi bers and the formation of mul-
tiple actin spikes and ruffl ing lamellipodia throughout the entire 
cell body ( Fig. 3 C and Video 1, available at http://www.jcb
.org/cgi/content/full/jcb.200802091/DC1); N-cadherin and ERM 
were highly concentrated at these sites ( Fig. 3 D , arrowheads). 
and multiple long and thin processes that failed to properly 
elongate along axons ( Fig. 2, D and E ). In addition, defects in 
  2 laminin expression and basal lamina organization were also 
observed ( Fig. 2 D ). Collectively, these data suggest that knock-
down of myosin II in SC impairs their ability to properly polar-
ize, associate with axons, and myelinate. 
 Myosin II regulates localized actin 
protrusive activity and is necessary 
to establish proper SC polarity and 
contact with the axon 
 Several studies have demonstrated a direct role of myosin II in 
the control of cell polarity and localized actin-protrusive activ-
ity, which are essential for directed migration ( Lo et al., 2004 ; 
 Even-Ram et al., 2007 ). To further evaluate the effects of myo-
sin II inhibition on SC morphology and polarity, we analyzed 
the changes in actin cytoskeleton and actin-associated proteins 
in cultures treated with blebbistatin. In control cultures, SC dis-
 Figure 3.  Myosin II regulates actin protrusive 
activity and is necessary to establish proper 
SC polarity. Subconﬂ uent SC cultures stained 
with phalloidin and antibodies to N-cadherin, 
MLC, and vinculin. (A and B) In control cul-
tures, SC display abundant cortical actin and 
stress ﬁ bers (dotted line). MLC staining is also 
found at stress ﬁ bers (insets 1 and 3) but not 
at focal adhesions (arrowheads, inset 3). (B) 
Two randomly polarized (front-to-back) SC 
showing concentration of N-cadherin staining 
in actin-rich protrusions at the leading edge 
(arrowheads) and also at the tip of the cell tail 
(asterisks, inset 2). Accumulation of MLC is ob-
served at the retracting tail (inset 2), where it 
colocalizes with vinculin (inset 4). (C and D) 
SC treated with blebbistatin (25  μ M for 60 min) 
display striking changes in the organization of 
the actin cytoskeleton, including loss of stress 
ﬁ bers and the formation of multiple actin 
spikes throughout the entire cell body, where 
N-cadherin is highly concentrated (arrowheads). 
Many long and very thin cell processes (as-
terisks) are also observed in treated cultures. 
(E – H) SC-DRG cocultures maintained for 3 d in 
myelin-promoting media with or without bleb-
bistatin and stained for N-cadherin, neuroﬁ la-
ment, and Hoechst nuclear staining. In control 
conditions (E and F), SCs that are starting to 
elongate (asterisks) show a  “ track-like ” pattern 
of N-cadherin staining along the axons they 
contact (broken line). In blebbistatin-treated 
cultures (G and H), multipolar SCs (asterisks) 
extend many N-cadherin – positive processes 
toward various axons. Staining in these pro-
cesses at the SC – axon interface (dotted line) 
does not show the track-like pattern found in 
controls. Arrowheads indicate processes with 
patchy N-cadherin staining that do not align 
with any axon in the ﬁ eld. Bars, 10  μ m. 
JCB • VOLUME 182 • NUMBER 6 • 2008 1176 
 Figure 4.  Myosin II inhibition in oligodendrocyte-DRG cocultures enhances myelin formation.  (A) Puriﬁ ed OL progenitors (OPC) were seeded onto 3-wk-old 
DRG neuronal cultures. After 2 wk in media containing 1  μ g/ml TrkA-Fc, cultures were stained for Olig2, MBP, and neuroﬁ lament. Treatment with bleb-
bistatin resulted in a prominent dose-dependant increase in the amount of myelin segments formed in cultures. (B) Quantitation of myelin segments (left), 
OL cell number (middle), and MBP expression (right) in control and blebbistatin-treated cultures. A signiﬁ cant dose-dependent increase in the amount of 
MBP + segments was observed in cultures treated with blebbistatin (P  < 0.001, ANOVA). The percentage of MBP + cells is comparable in all conditions, and 
at the highest blebbistatin concentration (25  μ M), a signiﬁ cant reduction in the number of Olig2 + cells was observed. Data represent mean  ± SEM from 
two independent experiments (two cultures per condition per experiment). (C, left) Quantitation of the number of myelin segments formed per single OL in 
cultures. Low-density 16-d-old myelinating cocultures were stained for Olig2, MBP, and neuroﬁ lament to identify individual OL nuclei, OL expressing MBP, 
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and OL actively myelinating axons. A signiﬁ cant increase in the mean number of myelin segments made by a single OL in treated cultures was observed 
(P  < 0.001, ANOVA). Data represent mean  ± SEM from two independent experiments (two cultures per condition per experiment). (right) Representative 
examples of myelinating OL in control and treated cultures are shown. Bars: (A) 50  μ m; (C) 20  μ m. 
Many long and very thin dendrite-like processes were also ob-
served in treated cultures ( Fig. 3 B , asterisks). 
 Because perturbation of N-cadherin function in SC-DRG 
cocultures also results in multipolar SC that do not align with 
axons ( Wanner and Wood, 2002 ), we next examined the distribu-
tion of N-cadherin in premyelinating SC-DRG cocultures treated 
with blebbistatin. As described previously ( Wanner and Wood, 
2002 ), accumulation of N-cadherin in a  “ track-like ” staining pat-
tern was observed along the SC – axon interface in control cul-
tures ( Fig. 3, E and F ). This distribution was dramatically affected 
by blebbistatin treatment, as multipolar SC extended many 
N-cadherin – positive processes toward different axons ( Fig. 3, 
G and H ). The pattern for N-cadherin staining along these pro-
cesses was different from that observed in control cultures ( Fig. 3, 
E and F ), and although some patchy accumulation was observed 
at points of SC – axon contact, they were not restricted to these 
sites but were also found in processes that did not contact axons 
( Fig. 3, G and H ). Thus, our data suggest that myosin II in SC 
restricts actin protrusive activity, which in turn is important to 
establish SC polarity and proper contact with the axon. 
 Myosin II inhibition in OL-DRG cocultures 
enhances myelin formation 
 We next examined whether myosin II was also required for cen-
tral myelination. To this end, cocultures of DRG neurons and 
purifi ed rat cortical OL precursor cells (OPC) were grown for 
2 wk in myelination-promoting conditions with or without bleb-
bistatin. Cultures were then stained for Olig2, MBP, and neuro-
fi lament to identify individual OL nuclei, OL expressing MBP, 
and those actively myelinating axons. In striking contrast to SC 
myelination, inhibition of myosin II activity by blebbistatin re-
sulted in a prominent increase in the amount of myelin formed 
in DRG-OL cocultures ( Fig. 4 A ). Quantitation of the number 
of MBP + segments showed a signifi cant dose-dependent in-
crease (P  < 0.001, analysis of variance [ANOVA]) in the amount 
of MBP + segments in cultures treated with blebbistatin ( Fig. 4 B ). 
Interestingly, despite the difference in the total number of my-
elin segments, we found that differentiation of OL as measured 
by MBP expression ( Fig. 4 B ) was comparable between control 
and treated cultures (  70 – 80% MBP + cells). Furthermore, at 
the highest blebbistatin concentration tested (25  μ M), a signifi -
cant decrease in proliferation (Table S1) and in the total number 
of Olig2 + cells was consistently observed, yet these cultures 
had, on average, more myelinated segments per fi eld than con-
trol cultures (P  < 0.001). These results strongly suggest that in 
blebbistatin-treated cultures, individual myelinating OL give 
rise to more internodes than OL in control cultures. To facilitate 
the quantitation of the number of internodes made by a single 
myelinating OL, we established cocultures with a lower number 
of OPC (50,000 instead of 100,000). As anticipated, the mean 
number of myelin segments made by a single OL in blebbi-
statin-treated cultures was 3 – 4 times more than OL in control 
cultures (control, 4.8  ± 3.5; 10  μ M blebbistatin, 14.6  ± 5.5; 25  μ m 
blebbistatin, 18.5  ± 9.3; mean  ± SEM; P  < 0.001;  Fig. 4 C ). 
Collectively, these results indicate that myosin II activity is not 
required for OL differentiation and myelination, and that in the 
presence of blebbistatin, individual OL are more branched and 
make more myelin. 
 Knockdown of myosin II in 
OL-DRG cocultures by shRNA 
enhances myelin formation 
 To further investigate the contribution of OL myosin II on my-
elin formation, we infected OPC-DRG cocultures with shRNA 
lentivirus against the regulatory chain of MLC. Lentiviral infec-
tion of purifi ed OPC cultures resulted in signifi cant cell death 
(unpublished data), whereas infection of OPC in cocultures with 
DRG neurons was well tolerated. Incubation of cocultures with 
lentivirus resulted in the preferential infection of OPC rather 
than neurons, as indicated by GFP expression (Fig. S3, available 
at http://www.jcb.org/cgi/content/full/jcb.200802091/DC1). As 
a further control, we infected established DRG cultures with the 
lentivirus for several days before adding OPC and inducing my-
elination. As shown in  Fig. 5 , knockdown of MLC in OPC-DRG 
cocultures also resulted in a signifi cant increase (P  < 0.001) in 
myelination similar to that observed in cultures treated with 
blebbistatin. Myelination in the presence of nontargeting lenti-
virus (shSCR) or vector alone was comparable to that observed 
in nontreated control cultures. In addition, myelination of neurons 
preinfected with lentivirus was comparable to controls (unpub-
lished data), which further indicates that enhanced myelination 
results from the specifi c inhibition of myosin II in OL. 
 Inhibition of myosin II increases the 
complexity of OL branching in cultures 
 To further characterize the effects of myosin II inhibition on 
OL, we measured the effects of blebbistatin treatment on prolif-
eration, survival, and differentiation of purifi ed OPC cultures. 
In contrast to OPC in coculture with neurons, where we found a 
decrease in proliferation at the highest drug dose (Table S1), 
blebbistatin had no signifi cant effect on the proliferation of pu-
rifi ed OPC maintained for 3 d in media containing PDGF and 
basic FGF (bFGF; 35.6  ± 1.3% [control] vs. 35  ± 1.1% [25  μ M 
blebbistatin]; mean percentage BrdU  ± SEM; P  > 0.05). Stain-
ing for caspase 3 revealed a slight increase in the percentage of 
apoptotic cells in blebbistatin-treated cultures; however, this 
difference was not statistically signifi cant (3.3  ± 0.4% [control] 
vs. 4.6  ± 0.7% [25  μ M blebbistatin]; mean  ± SEM, P  > 0.05). 
Thus, we concluded that inhibition of myosin II did not have a 
signifi cant impact on OPC proliferation and survival. 
 To evaluate differentiation, OPC cultures were kept for 3 d 
in media supplemented with T3 with or without blebbistatin and 
then stained for MBP expression. Unlike OPC in coculture with 
neurons, we found a modest but signifi cant increase in the per-
centage of cells expressing MBP in blebbistatin-treated cul-
tures compared with control (40  ± 1.7% [control] vs. 49  ± 2% 
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entiating media and increase their MBP expression, the levels 
of myosin IIB are strikingly down-regulated. Staining of OPC 
cultures similarly showed that myosin II is expressed at high 
levels in OPC before their differentiation and MBP expression 
(Fig. S4, available at http://www.jcb.org/cgi/content/full/jcb
.200802091/DC1). In vivo, myosin II and phosphorylated MLC2 
are also down-regulated before myelination, as indicated by West-
ern blots of rat brains collected at different developmental stages 
( Fig. 6 D ). Because myosin II is a known regulator of actin 
bundle turnover ( Guha et al., 2005 ;  Medeiros et al., 2006 ), we 
examined whether down-regulation of myosin II correlates with 
changes in the expression of proteins involved in promoting ac-
tin polymerization and branching. As shown in  Fig. 6 D , the 
expression levels of WAVE and neuronal Wiskott-Aldrich syn-
drome protein (N-WASP) were increased at the onset of MBP 
expression in OPC and brain extracts, in accordance with their 
proposed role in myelin formation ( Kim et al., 2006 ;  Bacon 
et al., 2007 ). In contrast, the levels of total actin and Arp2/3 
remained unchanged, whereas the levels of phosphorylated (in-
active) cofi lin were down-regulated, which is consistent with the 
role of the nonphosphorylated (active) form in promoting actin 
polymerization ( Huang et al., 2006 ). Collectively, these results 
suggest that down-regulation of myosin II activity is part of the 
 “ default ” differentiation program of OL in vitro and in vivo and 
might play a role in promoting actin polymerization at the onset 
of myelination. 
 Discussion 
 In this study, we have shown that myosin II differentially regu-
lates myelin formation by SC and OL ( Fig. 7 ). Myosin II activ-
ity is required for proper interactions between SC and axons, and 
its inhibition or down-regulation impairs the ability of SC to 
segregate axons and elongate along them, preventing the forma-
tion of a 1:1 relationship, which is critical for their differentiation 
[treated]; mean  ± SEM; P  < 0.005;  Fig. 6 A ). OL in the blebbi-
statin-treated group also exhibit extensive membrane expansion 
( Fig. 6 A ), a change that has been correlated with myelin sheath 
formation ( Kachar et al., 1986 ;  Kim et al., 2006 ;  Sloane and 
Vartanian, 2007 ). We next examined the effects of blebbistatin 
treatment in OL morphological complexity and branching. We 
measured the fractal dimension of individual OL in control and 
blebbistatin-treated cultures. An increase in fractal dimension 
has been correlated with OL maturation in culture ( Behar, 2001 ). 
We found that treatment with blebbistatin signifi cantly increased 
the mean fractal dimension of OL in cultures (1.37  ± 0.12 [con-
trol] vs. 1.46  ± 0.08 [treated] mean  ± SEM; P  < 0.001;  Fig. 6 B ), 
which indicates more complex cytoskeleton branching in the 
absence of myosin II activity. Real-time studies also revealed a 
dramatic increase in protrusive activity along the OPC cell body 
and branches, with extensive formation of fi lopodia and ruffl ing 
lamellipodia. We also observed the development of new branches 
within 15 – 30 min of treatment with blebbistatin via the coales-
cence of some of these processes (Videos 2 and 3, available at 
http://www.jcb.org/cgi/content/full/jcb.200802091/DC1). These 
results suggest that myosin II inhibition infl uences OL morpho-
genesis by promoting complex branching and lamella forma-
tion, changes that have been correlated with myelin formation 
in vitro ( Kachar et al., 1986 ) and in vivo ( Kim et al., 2006 ; 
 Sloane and Vartanian, 2007 ). 
 Myosin II expression is down-regulated 
during OPC maturation in vitro and in vivo 
 We next examined whether the levels of myosin II protein ex-
pression change as OL mature in culture. Cell lysates were pre-
pared from purifi ed OPC cultures kept in proliferating media 
(PDGF + bFGF) for 3 d or differentiating media (T3) for 2 – 7 d. 
As shown in  Fig. 6 C , levels of myosin IIB (the main isoform 
found in OPC and brain) are high when OPC are maintained as 
proliferating progenitors. When cultures are switched to differ-
 Figure 5.  Knockdown of myosin II in OL-
DRG cocultures enhances myelin formation. 
(A) 3-wk-old myelinating OL-DRG cocultures 
stained for MBP, Olig2, and neuroﬁ lament. 
Cocultures were infected with a lentiviral vec-
tor expressing shRNA against the regulatory 
chain of myosin II (shMLC) or nontargeting 
scrambled sequence (shSCR). Knockdown of 
MLC in OPC-DRG cocultures resulted in a sig-
niﬁ cant increase in myelination similar to that 
observed in cultures treated with blebbistatin. 
Myelination in control cultures infected with 
vector alone or in cultures where neurons were 
preinfected with lentivirus was comparable to 
that observed in nontreated control culture (not 
depicted). Bars, 50  μ m. (B) Quantitation of 
MBP + segments per ﬁ eld. Data represent mean  ± 
SEM from two independent experiments (three 
cultures per condition per experiment). 
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 Figure 6.  Blebbistatin promotes OPC differentiation in vitro and increases the complexity of OL branching in cultures. (A) Puriﬁ ed OPC kept for 3 d 
in differentiation-promoting media in the absence or presence of 10  μ M blebbistatin. Staining for MBP revealed a slight but signiﬁ cant increase in the 
percentage of MBP + cells in myosin II – inhibited cultures. Examples of OL exhibiting extensive membrane expansion are indicated (arrowhead). Data in 
graph represent the mean  ± SEM of four independent experiments (two cultures per condition per experiment). Bar, 20  μ m. (B) Fractal analysis of OPC 
morphological complexity was performed in cultures kept for 3 d in differentiation-promoting media in the absence or presence of 10  μ M blebbistatin. The 
mean fractal dimension (D) in blebbistatin-treated cultures was signiﬁ cantly higher than control (1.37  ± 0.12 [control] vs. 1.46  ± 0.08 [treated]; mean  ± 
SD; P  < 0.0001;  t test), which indicates more complex cytoskeleton branching in the absence of myosin II activity. Representative examples of low- and 
high-complexity OPC stained with O4 are shown on the right. Bars, 10  μ m. (C) Western blot of OPC cultures kept in proliferating media (PDGF) for 3 d or 
differentiating media (T3) for 2 – 7 d. A signiﬁ cant reduction in the levels of myosin II (isoforms A and B) was found between cultures kept in proliferating 
conditions compared with T3. As OPC differentiate, the levels of myosin II are further down-regulated. (D) Developmental expression proﬁ le of myosin II, 
actin-binding proteins, and MBP in rat brain lysates. The levels of myosin IIB and the phosphorylated regulatory chain (pMLC2) are down-regulated as my-
elination progresses in rat CNS, whereas total MLC2 remain unchanged. Total actin and Arp2 also remain constant, but the levels of WAVE1 and N-WASP, 
proteins that are involved in actin polymerization, are up-regulated at the onset of myelination (P15). In addition, the levels of p-coﬁ lin are down-regulated 
at this stage, which is consistent with the role of the nonphosphorylated form in promoting actin polymerization. 
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 Figure 7.  Summary of myosin II inhibition effects on myelination by SC 
and OL. Myosin II is an important regulator of SC cytoskeleton during dif-
ferentiation and myelination. Myosin II appears to be necessary for the 
establishment of SC polarity and elongation along the axons, a crucial step 
in the initiation of myelin formation in the PNS. In the absence of myosin II 
activity, SC are unable to segregate axons in a 1:1 relationship and myeli-
nate. In contrast, OL differentiation and myelin formation are independent 
of myosin II activity. Furthermore, down-regulation of myosin II promotes 
actin polymerization and branching, and also results in a signiﬁ cant in-
crease in the amount of myelinated segments formed in culture. 
and myelination. In contrast, OL branching and myelin forma-
tion are potentiated by inhibition or down-regulation of myosin II. 
Thus, by controlling the spatial and localized activation of actin 
polymerization, myosin II regulates SC polarization along 
the axon and OL branching, and thereby their ability to form 
myelin. These results indicate that the mechanisms regulating 
myelin formation in the PNS and CNS are distinct. 
 Myosin II is a key regulator of SC 
cytoskeleton polarity, differentiation, 
and myelination 
 We have presented evidence that myosin II activity is an impor-
tant regulator of SC cytoskeleton organization during differen-
tiation and myelination. SC lacking myosin II activity exhibit a 
multipolar morphology, with round nuclei and multiple long 
processes that fail to elongate properly along the axons and 
myelinate. Multipolar morphology is also observed in myosin II –
 null fi broblasts ( Lo et al., 2004 ;  Even-Ram et al., 2007 ), which 
are unable to move in a directed and persistent manner. Thus, 
the failure to segregate and eventually myelinate the axons they 
contact might be partly explained by the inability of multipolar 
SC to orient their cytoskeleton and move in a directed manner, 
following cues from the axon and the ECM. EM analysis 
corroborated these observations, demonstrating that in myosin 
II – inhibited cocultures, SC associate with but fail to completely 
ensheath axons. Similarly, expression of myelin-specifi c proteins 
and transcription factors, and the amount of myelin formed in 
myosin II – inhibited cocultures, was greatly reduced. In agree-
ment with these results, disruption of actin polymerization by 
cytochalasin D inhibits SC elongation, myelin-specifi c mRNA 
expression, and myelination ( Fernandez-Valle et al., 1997 ). Like-
wise, defects in SC polarity, regulation of actin-protrusive activ-
ity, and axon alignment have been shown in merlin-defi cient 
Schwannoma cells and are thought to be involved in the process 
of dedifferentiation of these tumor cells ( Nakai et al., 2006 ; 
 Flaiz et al., 2007 ). 
 We postulate that, akin to its role in epithelial cells, myo-
sin II plays a key role in SC polarity in regulating the formation, 
localization, and spreading of cell – cell contacts between SC 
processes and axons. Myosin II – mediated contractility controls 
the accumulation of adhesion complexes and the establishment 
of epithelial cell polarity ( Ivanov et al., 2005 ;  Miyake et al., 2006 ) 
and also helps to maintain adhesion and cadherin accumulation 
at the apical border of epithelial cells ( Shewan et al., 2005 ; 
 Ma et al., 2007 ). 
 These observations are likely to be relevant to the initial 
interactions between SC and axons, as during their development, 
SC acquire a distinct polarity with an adaxonal region contacting 
the axon and abaxonal surface in contact with the basal lamina 
( Bunge and Bunge, 1986 ). As for epithelial cell function, the de-
velopment of this polarity is essential for SC differentiation and 
myelination and also plays a key role in establishing the different 
functional domains of myelinated axons ( Salzer, 2003 ). 
 The initial contact and alignment of SC processes with the 
axons they myelinate is mediated by the accumulation of cell-
adhesion molecules such as N-cadherin along the SC – axon in-
terface ( Wanner and Wood, 2002 ), where it colocalizes with the 
polarity protein Par-3 ( Chan et al., 2006 ). We have found that 
myosin II inhibition perturbs N-cadherin accumulation at sites 
of SC – axon contact and results in a multipolar SC that is unable 
to align along the axons, which is similar to that resulting from 
disrupting N-cadherin function ( Wanner and Wood, 2002 ). Thus, 
loss of actomyosin contractility and delocalized accumulation 
of cell adhesion complexes might in part explain the effects in 
SC morphology and differentiation caused by the inhibition or 
down-regulation of myosin II activity. 
 Down-regulation of myosin II activity 
promotes actin polymerization, 
oligodendrocyte branching, 
and myelin formation 
 In contrast to SC, terminal differentiation of OL is paradoxi-
cally promoted in the absence of myosin II activity. Thus, the 
percentage of OPC expressing MBP, the complexity of OL branch-
ing, and the amount of myelin segments formed in culture by 
individual cells are all increased. These results indicate that 
myosin II activity modulates key aspects of OL morphogenesis 
and myelination. In potential agreement, there is an inverse cor-
relation between the levels of MBP and myosin II expression, 
which suggests that down-regulation of myosin II activity may 
be an obligate component of the differentiation program of OPC 
in vitro and in vivo . Interestingly, recent functional genomics 
studies have shown that Myh10, the heavy chain of nonmuscle 
myosin IIB, is enriched in acutely purifi ed OPC and is similarly 
down-regulated during OL terminal differentiation ( Dugas et al., 
2007 ;  Cahoy et al., 2008 ). 
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pression of SC branching and the establishment of proper cell 
polarity ( Melendez-Vasquez et al., 2004 ). However, unlike inhi-
bition of ROCK-mediated MLC phosphorylation, which promotes 
the coordinated wrapping of the axon, inhibition of myosin II 
ATPase activity by blebbistatin or down-regulation of myosin II 
total levels by shRNA completely blocked myelin formation. 
These contrasting effects provide compelling evidence for the 
existence of different mechanisms controlling myosin II activity 
within the SC, as has been demonstrated in other cell types 
( Totsukawa et al., 2000 ,  2004 ). 
 In OL, constitutive activation of Rho interferes with OL 
branching and maturation ( Wolf et al., 2001 ;  Liang et al., 2004 ). 
Although direct proof is lacking, inactivation of Rho might af-
fect myosin II activity in OL via down-regulation of ROCK ac-
tivity and, hence, MLC phosphorylation. Our results showing 
that the expression levels of phosphorylated MLC by OPC are 
higher before MBP up-regulation both in vivo and in vitro and 
that down-regulation of myosin II levels and activity promotes 
myelination are consistent with this model. Interestingly, phos-
phorylation of myosin II by ROCK has been identifi ed as a neg-
ative regulator of F-actin polymerization in developing growth 
cones ( Loudon et al., 2006 ), providing a possible mechanism 
for the regulation of OL branching and differentiation via the 
Rho – ROCK – myosin II pathway. 
 Myosin II has three isoforms, IIA, IIB, and IIC, which are 
differentially localized and regulated in many cell types and that 
appear to have different functions during cell migration and 
spreading ( Conti and Adelstein, 2008 ). We have found that SC 
express all three isoforms, although in cocultures, myosin IIB 
predominates over IIA and IIC at the initial stages of axon – SC 
contact, whereas IIC is up-regulated in myelinating SC (unpub-
lished data). In SC-only cultures, myosin IIB and MLC staining 
are colocalized at the tip of the retracting tail, in stress fi bers, and 
at the leading edge of polarized cells ( Fig. 3 and not depicted). 
OL also express all three myosin II isoforms. Myosin IIB is the 
main isoform detected in OPC in vitro and in vivo during early 
development, whereas myosin IIC, which is not detected at early 
stages, predominates in differentiated OL ( Cahoy et al., 2008 ) and 
in adult brain ( Golomb et al., 2004 ). Myosin IIB is also the pre-
dominant isoform expressed at the leading edge of OL processes 
together with actin ( Song et al., 2001 ), making it a good candidate 
to mediate the effects of myosin II inhibition on OL myelination. 
In agreement with this idea, we have found that siRNA knock-
down of myosin IIB in OPC has the same effect on OL myelina-
tion as MLC2/myosin II down-regulation (unpublished data). 
 Collectively, these data suggest that differential spatial 
regulation of myosin II isoforms by various kinases or the GTPases 
that in turn control these enzymes might play a key role in my-
elination. Of note, activation of Rac-GTPase downstream of 
  1-integrin has been shown to play an important role in SC pro-
cess extension, axonal sorting, and myelination ( Benninger 
et al., 2007 ;  Nodari et al., 2007 ). Because delocalized activation 
of Rac and membrane ruffl ing in myosin II – null fi broblasts has 
been shown to cause defects in polarized cell migration ( Even-Ram 
et al., 2007 ), it will be of interest to determine the activation 
status of myosin II in the nerves of conditional   1-integrin or 
Rac knockout mice. 
 OPC in culture differentiate progressively through a se-
quence of stages characterized by distinct morphologies and 
expression of specifi c markers ( Pfeiffer et al., 1993 ). As OPC 
mature and form lamella, the complexity and branching of their 
cytoskeleton increases ( Behar, 2001 ). These cytoskeletal changes 
have been linked to OL differentiation and myelin formation in 
vitro and in vivo ( Kachar et al., 1986 ;  Kim et al., 2006 ;  Sloane 
and Vartanian, 2007 ). The importance of the actin cytoskeleton 
during these events is highlighted by the myelination defi cits 
exhibited by mice defi cient for WAVE-1, an actin-associated 
protein important for lamellipodia formation ( Kim et al., 2006 ). 
In vitro, OPC from WAVE1-null mice have fewer processes and 
defective lamella formation, and also exhibit regional CNS 
hypomyelination ( Kim et al., 2006 ). 
 In the present study, we identify an inverse correlation be-
tween myosin II activity and OPC branching and myelination. 
Thus, in OPC cultures, down-regulation of myosin II appears to 
promote actin polymerization and branching, changes that trans-
late into more myelin segments formed in culture by individual 
OPC. Although the direct role of myosin II in actin turnover is 
still not well understood, recent in vitro studies have shown that 
myosin II can act as an actin-depolymerizing agent ( Haviv et al., 
2008 ), and that at high myosin II concentrations, the formation 
and growth of actin fi lament bundles is inhibited. This study also 
found that in the presence of blebbistatin, the density of actin fi la-
ments is higher, suggesting that  “ inactive motors ” act as passive 
actin cross-linkers ( Haviv et al., 2008 ). Of note, a similar role for 
myosin II as a negative regulator of actin polymerization during 
growth cone development and consolidation has been described 
previously ( Medeiros et al., 2006 ). As the distal tips of OL pro-
cesses resemble growth cones in their behavior and molecular 
composition ( Fox et al., 2006 ), myosin II may have a similar role 
in regulating the actin cytoskeleton in both structures. 
 Regulation of myosin II activity during 
myelin formation 
 The mechanisms that regulate myosin II activity in SC and OL 
during myelination are not yet known. In SC, phosphorylation 
of the regulatory chain of myosin II (MLC2) is up-regulated at 
the onset of myelination and then down-regulated ( Melendez-
Vasquez et al., 2004 ), following the same pattern of Rho activa-
tion in peripheral nerve extracts (unpublished data). Our previous 
studies revealed an important role for ROCK during the initial 
events of PNS myelination, possibly by regulating the phosphory-
lation status of MLC ( Melendez-Vasquez et al., 2004 ). How-
ever, inhibition of ROCK did not interfere with the wrapping of 
the axon, which suggests that another ROCK-independent mech-
anism controls the actual motor of SC adaxonal membrane pro-
gression around the axon. Our current study extends these initial 
observations and provides further evidence of the important role 
of polarized actomyosin contraction for SC myelin formation. 
Similar to our previous results with a ROCK-specifi c pharmaco-
logical inhibitor, the effects of myosin II inactivation on SC my-
elination are more marked when the inhibition occurs at the 
early stages of myelin formation, with little effect on older cul-
tures. This early requirement for ROCK and myosin II activity 
at the onset of myelination appears to be important for the sup-
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seeded directly onto DRG explants in MEM media containing 10% FBS, 
2 mM  L- glutamine, and 0.4% glucose. Myelination was induced the following 
day by addition of 1  μ g/ml TrkA-Fc (R & D Systems). For studies of the effects 
of myosin II inhibition on myelination, blebbistatin (EMD) was also added to 
the media at this point and maintained throughout the experiment. Cultures 
were allowed to myelinate up to 18 d, with fresh media provided every 2 – 3 d. 
Myelin segments were identiﬁ ed by MBP and neuroﬁ lament staining, then 
counted in micrographs from 8 – 10 random low-power ﬁ elds per coverslip 
using ImageJ version 1.38 (total of 16 – 20 ﬁ elds per condition per experi-
ment; total of 2 – 3 experiments). Statistical tests ( t test and ANOVA) were 
performed using GraphPad Prism software. 
 RNAi of myosin II in puriﬁ ed glia and myelinating cocultures 
 To generate shRNAs, we used the pLentiLox (pLL3.7) vector (provided by 
L. Van Parijs, Massachusetts Institute of Technology, Cambridge, MA;  Rubinson 
et al., 2003 ). Two 19-nucleotide shRNAs (MLC1, 5  -GCACGGAGCG A-
AAGACAAA-3  ; and MLC2, 5  -GAGGCCTTCAACATGATCG-3  ) targeting 
the regulatory (light) chain of rat myosin II (MLC) were designed using Easy 
siRNA (ProteinLounge). The 5  -phosphorylated PAGE-puriﬁ ed oligonucle-
otides were annealed and subcloned into HpaI – XhoI sites of pLL3.7. The 
lentiviral vector was transfected into 293FT cells together with packaging 
plasmids   8.9 and pCMV-VSVG (provided by J. Milbrandt, Washington 
University, St. Louis, MO) using Lipofectamine 2000 (Invitrogen). As control, 
we used the empty pLL3.7 vector or a vector encoding shRNA to a nontarget-
ing (scrambled) sequence. Viral supernatants were collected 72 h after trans-
fection, centrifuged at 3,000 rpm for 15 min, aliquoted for one-time use, and 
frozen at   80 ° C. Freshly plated SC were incubated for 3 d with viruses at a 
2:3 dilution (vol/vol) in D media (DME, 10% FBS, and 2 mM L- glutamine) 
supplemented with forskolin and rhNRG-  1 (EGF domain). Cells were ex-
panded for an additional week and maintained for 3 d in D media before 
use for myelination experiments. Protein knockdowns were conﬁ rmed by 
Western blotting. For shRNA knockdown experiments in OPC-DRG cocul-
tures, cultures were incubated with lentivirus supernatant at 1:3 dilution for 2 d. 
The virus was removed and cultures were allowed to myelinate for an addi-
tional 2 wk. This protocol resulted in the effective infection of OPC over 
neurons. As a control, we used established DRG cultures that were infected 
with the virus before adding the OPC and inducing myelination. 
 Antibodies 
 Antibodies used in these studies included those reactive to: MBP (SMI-94) 
and neuroﬁ lament (SMI-31 and SMI-32; Sternberger Monoclonals); myosin 
IIA and IIB (Covance), coﬁ lin, phosphorylated coﬁ lin, MLC2, phosphory-
lated MLC2, phosphorylated FAK, Arp2, and vinculin (Cell Signaling 
Technology); phalloidin-FITC, phalloidin-coumarin, rabbit anti-EHS lami-
nin, anti – caspase 3, and anti-actin (Sigma-Aldrich); anti-GFP, WAVE-1, 
and Olig2 (Millipore); anti – N-WASP (H100; Santa Cruz Biotechnology, 
Inc.); anti – N-cadherin and anti-Tau (BD Biosciences). Polyclonal anti-
bodies to Krox-20 and Oct-6 (provided by D. Meijer, Erasmus University, 
Rotterdam, Netherlands), P0 (M. Filbin, Hunter College, City University of 
New York, New York, NY), laminin   -2 chain (P. Yurchenco, Robert 
Wood Johnson Medical School, University of Medicine and Dentistry of 
New Jersey, Piscataway, NJ) and myelin-associated glycoprotein were 
also used. Mouse A2B5 and Ran-2 hybridomas were obtained from the 
American Type Culture Collection. Mouse O4 was a gift from M. Chao 
(New York University, New York, NY). Secondary antibodies conjugated 
to rhodamine, ﬂ uorescein, coumarin, or cyanin 5 were obtained from 
Jackson ImmunoResearch Laboratories. 
 Immunoﬂ uorescence 
 Cultures (SC, OPC, and myelinating cocultures) were ﬁ xed in 4% PFA and 
processed for immunocytochemistry as described previously ( Melendez-
Vasquez et al., 2004 ). For surface antigen staining (A2B5 and O4), cells 
were blocked with 1% donkey serum and 5% BSA in PBS for 30 min, then 
incubated with primary antibody as described previously ( Zhang et al., 
2006 ). Cultures were examined by epiﬂ uorescence or confocal micros-
copy (see the following paragraph). 
 Image acquisition and analysis 
 Epiﬂ uorescence images were acquired using a microscope (DMI 4000B; 
Leica) with LAS 1.7.0 software equipped with a digital camera (DFC350FX; 
Leica) and the following objectives: N PLAN 10 × /0.25 NA; N PLAN L 
40 × /0.55 NA; and HCX PL APO CS 63 × /1.4 NA oil UV (all from Leica). 
Confocal images were acquired with a laser scanning microscope (LSM 
510; Carl Zeiss, Inc.) using Plan-Apochromat 20 × /0.75 NA or Neoﬂ uor 
40 × /1.3 NA oil objectives and LSM software (all from Carl Zeiss, Inc.). 
Image processing and quantitation (including fractal analysis) was performed 
 Myelination in the CNS and PNS is 
differentially regulated by myosin II 
 Although SC and OL have a conserved function as myelin-
forming cells, they differ in developmental origin ( Jessen and 
Mirsky, 2005 ;  Richardson et al., 2006 ) and key aspects of their 
cell biology, including their response to axon-derived signals 
during terminal differentiation and myelination ( Stevens et al., 
1998 ,  2002 ;  Chan et al., 2004 ;  Taveggia et al., 2005 ,  2008 ) and 
the different patterns of association with the axons they myelin-
ate. Thus, SC and OL initially extend processes and associate 
with several axons, but whereas a single OL can wrap up to 40 
axons simultaneously, individual SC will ultimately segregate 
and myelinate only one axon. Central myelinated axons also 
lack the basal lamina characteristic of SC myelination. In this 
study, we have shown that by controlling SC polarization along 
the axon and promoting OL branching, myosin II differentially 
regulates their ability to form myelin. Our fi ndings provide a 
novel conceptual framework for how the different patterns of 
SC and OL myelination are established and indicate that the 
mechanisms regulating glial cell differentiation and myelina-
tion in the PNS and CNS are fundamentally different. Further 
studies on the signals that regulate myosin II activity in SC and 
OL should help to clarify its role during myelin formation. 
 Materials and methods 
 Myelinating SC-DRG cocultures 
 DRG neurons were isolated from embryonic day 16 rat spinal cords and 
either trypsinized or directly plated as explants on collagen-coated cover-
slips (BD Biosciences). Cultures were maintained in serum-free neurobasal 
medium (NB medium; 2% B27 supplement, 2 mM L- glutamine, 0.4% glu-
cose, and 50 ng/ml 2.5S NGF). Nonneuronal cells were removed by 
feeding the cultures with NB medium containing 5-ﬂ uorodeoxyuridine and 
uridine. SC were isolated from postnatal day 2 sciatic nerves and ex-
panded for   3 wk in D media (DME, 10% FBS, and 2 mM L- glutamine) 
supplemented with 4  μ M forskolin and 5 ng/ml of the EGF domain of 
rhNRG-1-  1 (R & D Systems). Myelinating cocultures were established by 
seeding puriﬁ ed DRG neuron cultures with 100,000 SC in C media (MEM, 
10% FBS, 2 mM L- glutamine, 0.4% glucose, and 50 ng/ml 2.5S NGF). 
After 3 d, cocultures were changed to media supplemented with 50  μ g/ml 
ascorbic acid to initiate basal lamina formation and myelination. For stud-
ies of the effects of myosin II inhibition on myelination, cocultures were 
switched to myelin-promoting media containing blebbistatin (EMD). Con-
trol and treated cultures were allowed to myelinate for 2 – 3 wk, with fresh 
media provided every 2 – 3 d. To determine the extent of myelination in 
SC-DRG cocultures, the total number and length of MBP + segments were 
counted in micrographs from 10 – 12 random low-power ﬁ elds per cover-
slip using ImageJ version 1.38 (total of 20 – 24 ﬁ elds per condition per ex-
periment; total of 2 – 3 experiments). Statistical tests ( t test and ANOVA) 
were performed using GraphPad Prism (GraphPad Software). 
 Puriﬁ ed OPC cultures and OPC-DRG myelinating cocultures 
 Primary OL precursors (OPC and A2B5 + ) were puriﬁ ed by immunopanning 
from mixed glial cultures of postnatal day 1 rat cerebral cortices as de-
scribed previously ( Taveggia et al., 2008 ). Puriﬁ ed OPC were seeded onto 
poly-lysine – coated glass coverslips and maintained in Sato media (DME, 
100  μ g/ml transferrin, 100  μ g/ml BSA, 20 nM progesterone, 100  μ M pu-
trescine, 30 nM sodium selenite, 2 mM L- glutamine, 5  μ g/ml insulin, 60  μ g/ml 
N-acetyl cysteine, and 10  μ M forskolin) with 10 ng/ml PDGF and 10 ng/ml 
bFGF for proliferation or induced to differentiate in Sato containing T3 
(30 ng/ml). DRG explants were isolated from rat embryonic day 16 spinal 
cords and plated directly onto glass coverslips coated with Matrigel (BD 
Biosciences). Explants were kept in NB medium and treated with antimitotic 
agents to eliminate nonneuronal cells. Explants were allowed to extend a 
dense neurite network for at least 2 – 3 wk before their use in coculture experi-
ments. OPC-DRG cocultures were established as described previously ( Chan 
et al., 2004 ). In brief, freshly puriﬁ ed OPC (50,000 – 100,000 cells) were 
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using ImageJ version 1.38 and Photoshop CS8 (Adobe). Adjustment of im-
age brightness or contrast was performed in some cases but without misrep-
resenting data. 
 Time-lapse microscopy 
 Videos were acquired with a DMI 4000B microscope system (see the previ-
ous section) ﬁ tted with a stage incubator and a temperature and CO 2 digital 
controller (CTI Controller 37000; Pecon). Cells were plated on poly-lysine – -
coated glass-bottomed 35-mm tissue culture dishes (MatTek) on D media 
(SC) or proliferating OPC media. Phase images from SC and OPC cultures 
were acquired for a period of 15 – 30 min using an N PLAN L 40 × /0.55 
NA objective. Cultures were maintained at 37 ° C and 5% CO 2 throughout 
the observation period. 
 Proliferation and survival assays 
 To investigate the effect of myosin II inhibition on the proliferation and cell 
survival of SC and OPC, BrdU incorporation (Boehringer Mannheim Gmbh) 
and TUNEL assays (Promega) were performed according to manufacturers ’ 
instructions as described previously ( Melendez-Vasquez et al., 2004 ; 
 Zhang et al., 2006 ). 
 Cell extracts and Western blotting 
 Lysates from rat tissues (brain and nerves), cultures of SC, OPC, and myelinat-
ing cocultures were prepared as described previously ( Melendez-Vasquez 
et al., 2004 ), subjected to SDS-PAGE, and blotted onto nitrocellulose. Appro-
priate regions of the blots were cut and incubated with speciﬁ c antibodies 
and developed using chemiluminescent substrate (Thermo Fisher Scientiﬁ c). 
 Electron microscopy 
 Control and treated myelinating cocultures were rinsed in PBS, ﬁ xed over-
night at 4 ° C in 2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.0, and 
processed further as described previously ( Einheber et al., 1995 ). Specimens 
were examined on an electron microscope (CM10; Philips). 
 Online supplemental material 
 Fig. S1 shows changes in SC morphology after blebbistatin treatment in 
cocultures. Fig. S2 shows an example of SC forming multiple short inter-
nodes in blebbistatin-treated cultures. Fig. S3 shows preferential infection 
of OPC by lentivirus in cocultures. Fig. S4 shows expression of phosphory-
lated MLC during OPC differentiation in vitro. Table S1 shows the quantita-
tion of BrdU incorporation in PNS and CNS myelinating cocultures. Video 1 
shows formation of rufﬂ ing lamellipodia in SC after blebbistatin treatment. 
Videos 2 and 3 show actin-protrusive activity of an OPC before and after 
treatment with blebbistatin. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200802091/DC1. 
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